封面
市場調查報告書
商品編碼
1702389

全球黑蒜市場 - 2025-2032

Global Black Garlic Market - 2025-2032

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球黑蒜市場規模達到 1.1757 億美元,預計到 2032 年將達到 2.4411 億美元,在 2025-2032 年預測期內的複合年成長率為 8.46%。

由於消費者對黑蒜健康益處的認知不斷提高,以及對功能性食品和美食的需求不斷成長,黑蒜市場在全球呈現強勁成長。新研究的出現透過科學驗證了黑蒜的眾多健康益處,大大推動了黑蒜市場的成長。例如,2024 年《醫學新聞》發表的一項研究調查了 10-1,000 μg/mL 黑蒜萃取物對發炎和攝護腺癌的影響。

新聞醫學研究使用暴露於大腸桿菌脂多醣 (LPS) 的小鼠前列腺樣本體外發炎模型評估了黑蒜萃取物 (ABGE) 的抗發炎特性,突顯了其對抗發炎的潛力。然而,儘管其越來越受歡迎,但人們對其副作用(尤其是其血液稀釋特性)的擔憂對市場擴張構成了挑戰。

市場趨勢

隨著消費者越來越意識到黑蒜的抗氧化特性、調節膽固醇和抗發炎作用等健康益處,全球黑蒜市場正經歷顯著成長。這種趨勢在韓國、日本和泰國等國家尤其明顯,這些國家傳統上食用黑蒜,現在擴大將其包裝成功能性食品補充劑。

在美國和歐洲,黑蒜越來越受到注重健康的消費者和美食廚師的青睞,並進入了高級餐廳、素食產品和有機健康食品商店。例如,Black Garlic North America 和 Garlicious Grown(澳洲)等公司正在將其黑蒜產品線擴展為粉末、膠囊和糊狀形式,用於膳食補充劑。

動力學

黑蒜新研究的興起

新研究的興起為黑蒜市場的成長做出了重大貢獻,因為它為黑蒜的眾多健康益處提供了科學驗證。例如,根據2024年《醫學新聞》發表的一項研究,該研究評估了10-1,000 μg/mL黑蒜萃取物對發炎和前列腺癌的影響。

研究發現,黑蒜萃取物能夠抑制所有研究的發炎生物標記的基因表達,其中 1,000 µg/mL ABGE 被確定為最有效劑量。 ABGE 的抗發炎作用可能歸因於其眾多生物活性化合物的活性,例如兒茶素,它們可以調節 TNF-a、COX-2 和白細胞介素等發炎靶點。黑蒜萃取物似乎能夠對前列腺癌細胞系產生抗發炎和抗增殖作用,這表明這種補充劑在預防前列腺癌發展方面具有潛在作用。

食用黑蒜的副作用

黑蒜的副作用日益增多,尤其是其血液稀釋特性,這在消費者中引發了恐懼和謹慎,從而嚴重抑制了其市場的成長。大量使用黑蒜可能會產生抗凝血作用,這對某些已經有血液凝固問題或使用抗凝血藥物的人來說可能會有問題。它可能會導致手術後出血過多。

此外,黑蒜因其含硫化合物而具有抗凝血特性,這可能會增加出血的風險,特別是對於服用華法林等血液稀釋藥物的人。此外,黑蒜可能會引起某些人的過敏反應,尤其是對大蒜或相關化合物敏感的人。可能會出現皮疹、腫脹或呼吸問題等症狀,引起消費者的警覺。

目錄

第1章:方法論和範圍

第 2 章:定義與概述

第3章:執行摘要

第4章:動態

  • 影響因素
    • 驅動程式
      • 黑蒜新研究的興起
    • 限制
      • 食用黑蒜的副作用
    • 機會
    • 影響分析

第5章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監理與合規分析
  • 永續性分析
  • DMI 意見

第6章:依成分

  • 燈泡
  • 丁香
  • 果泥
  • 萃取物
  • 其他

第7章:依形式

  • 膠囊
  • 粉末
  • 軟糖
  • 其他

第 8 章:按應用

  • 心血管健康
  • 代謝健康
  • 大腦健康
  • 腎臟健康
  • 肝臟健康
  • 消炎劑
  • 其他

第9章:按銷售管道

  • B2B
  • B2C

第10章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 11 章:公司簡介

  • Pharmactive
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 關鍵進展
  • WISCONSIN FERMENTATION COMPANY LLC
  • Fermedics
  • Ayiana Pty Ltd
  • Black Garlic & Co.
  • Harmoni Group, Inc.
  • FutureYou Cambridge.
  • Garlicious Grown
  • The original black garlic
  • Hellenia Healthfoods

第 12 章:附錄

簡介目錄
Product Code: EP9456

Global black garlic market reached US$ 117.57 million in 2024 and is expected to reach US$ 244.11 million by 2032, growing with a CAGR of 8.46% during the forecast period 2025-2032.

The black garlic market is witnessing robust growth globally, driven by increasing consumer awareness of its health benefits and rising demand for functional and gourmet foods. The emergence of new research has significantly fueled the growth of the black garlic market by scientifically validating its numerous health benefits. For instance, a 2024 study published in News Medical examined the effects of 10-1,000 μg/mL black garlic extract on inflammation and prostate cancer.

The News Medical study assessed the anti-inflammatory properties of black garlic extract (ABGE) using an ex-vivo inflammation model with mouse prostate samples exposed to Escherichia coli lipopolysaccharide (LPS), highlighting its potential in combating inflammation. However, despite its growing popularity, concerns regarding side effects, particularly its blood-thinning properties, pose a challenge to market expansion.

Market Trends

The global black garlic market is experiencing notable growth due to rising consumer awareness of its health benefits, such as antioxidant properties, cholesterol regulation, and anti-inflammatory effects. This trend is especially prominent in countries like South Korea, Japan, and Thailand, where black garlic is traditionally consumed and now increasingly packaged as a functional food supplement.

In the US and Europe, black garlic is gaining traction among health-conscious consumers and gourmet chefs alike, driving its presence in high-end restaurants, vegan products, and organic health food stores. For instance, companies like Black Garlic North America and Garlicious Grown (Australia) are expanding their black garlic product lines into powders, capsules, and paste formats for dietary supplement applications.

Dynamics

The Rise of New Studies on Black Garlic

The rise of new studies has significantly contributed to the growth of the black garlic market by providing scientific validation of its numerous health benefits. For instance, according to a study published in News Medical, 2024, stated that the study evaluated the effects of 10-1,000 μg/mL black garlic extract on inflammation and prostate cancer.

Black garlic extract was found to inhibit the gene expression of all studied biomarkers of inflammation, with 1,000 µg/mL ABGE identified as the most effective dose. The anti-inflammatory effects of ABGE may be attributed to the activity of its numerous bioactive compounds, such as catechins, which modulate inflammatory targets like TNF-a, COX-2, and interleukins. Black garlic extract appears to induce anti-inflammatory and anti-proliferative effects on prostate cancer cell lines, thus suggesting this supplement's potential role in preventing prostate cancer development.

Side Effects Associated with Black Garlic Consumption

The rise of side effects associated with black garlic, particularly its blood-thinning properties, significantly restrains its market growth by instilling fear and caution among consumers. Using black garlic in large amounts may cause an anticoagulant effect, which could be problematic for certain people who already have blood clotting issues or use anticoagulant drugs. It can cause excessive bleeding following surgery.

Additionally, black garlic possesses anticoagulant properties due to its sulfur compounds, which may increase the risk of bleeding, particularly for individuals on blood-thinning medications such as warfarin. Moreover, black garlic can trigger allergic reactions in some individuals, particularly those with sensitivities to garlic or related compounds. Symptoms such as skin rashes, swelling, or respiratory issues may arise, leading to caution among consumers.

Segment Analysis

The global black garlic market is segmented based on ingredient, form, application, sales channel and region.

Black Garlic Gains Momentum in the Cardiovascular Health Segment

The cardiovascular segment is emerging as a major driver of the black garlic market, fueled by increasing scientific validation of its heart health benefits. Black garlic is particularly rich in antioxidants, notably S-allyl-cysteine (SAC), which plays a key role in reducing oxidative stress and inflammation-two critical contributors to cardiovascular disease.

Research has consistently shown that black garlic can support heart health by lowering cholesterol levels, enhancing blood circulation, and reducing blood pressure, making it an appealing natural intervention for individuals at risk of heart-related conditions. For instance, a 2022 study published by the National Library of Medicine highlighted the positive effects of aged black garlic on several cardiovascular disease (CVD) risk factors. Thus, the above factors help boost market growth.

Geographical Penetration

North America's Leading Role in the Black Garlic Market

The North American black garlic market is growing rapidly due to several key factors. One of the primary drivers is the increasing awareness of its health benefits, such as its rich antioxidant content, anti-inflammatory properties, and potential to support cardiovascular health. This has made black garlic particularly popular among health-conscious consumers who are seeking functional foods to improve their well-being.

Additionally, the rise in demand for natural and organic products has further boosted the market, as black garlic is often positioned as a natural alternative to synthetic supplements. For instance, according to the US Department of Agriculture, stated that, in the past decade, US organic retail sales increased by an average of 8 percent per year. In 2021, organic retail sales were estimated to be more than US$52 billion, about 5.5 percent of all retail food sales. US farms and ranches sold nearly US$11 billion in organic products in 2021. Imports are also helping to meet consumer demand.

Competitive Landscape

The major global players in the market include Pharmactive, WISCONSIN FERMENTATION COMPANY LLC, Fermedics, Ayiana Pty Ltd, Black Garlic & Co., Harmoni Group, Inc., FutureYou Cambridge, Garlicious Grown, The original black garlic, Hellenia Healthfoods and others.

Key Developments

  • In 2024, Boursin, a brand under Bel Brands US, introduced a new limited-edition flavor under its popular Boursin brand: Rosemary & Black Garlic. The company describes the latest addition as a rich and savory cheese with a balance of creamy and crumbly textures.

Why Choose DataM?

  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Ingredient
  • 3.2. Snippet by Form
  • 3.3. Snippet by Application
  • 3.4. Snippet by Sales Channel
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Rise of New Studies on Black Garlic
    • 4.1.2. Restraints
      • 4.1.2.1. Side Effects Associated with Black Garlic Consumption
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory and Compliance Analysis
  • 5.5. Sustainability Analysis
  • 5.6. DMI Opinion

6. By Ingredient

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 6.1.2. Market Attractiveness Index, By Ingredient
  • 6.2. Bulbs*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Cloves
  • 6.4. Purees
  • 6.5. Extracts
  • 6.6. Oil
  • 6.7. Others

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 7.1.2. Market Attractiveness Index, By Form
  • 7.2. Capsules*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Powder
  • 7.4. Gummies
  • 7.5. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiovascular Health*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Metabolic Health
  • 8.4. Brain Health
  • 8.5. Kidney Health
  • 8.6. Liver Health
  • 8.7. Anti-Inflammatory
  • 8.8. Others

9. By Sales Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.1.2. Market Attractiveness Index, By Sales Channel
  • 9.2. B2B*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. B2C

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. US
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. UK
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel

11. Company Profiles

  • 11.1. Pharmactive*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. WISCONSIN FERMENTATION COMPANY LLC
  • 11.3. Fermedics
  • 11.4. Ayiana Pty Ltd
  • 11.5. Black Garlic & Co.
  • 11.6. Harmoni Group, Inc.
  • 11.7. FutureYou Cambridge.
  • 11.8. Garlicious Grown
  • 11.9. The original black garlic
  • 11.10. Hellenia Healthfoods

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us